Written by: Tina Gagner

Have you ever read a word correctly at a glance, only to realize moments later it said something entirely different? In everyday situations, that kind of error is harmless. In healthcare, it can be life-threatening.

Look-alike, sound-alike (LASA) medications present a persistent risk in clinical environments, where providers must quickly interpret drug names under pressure. The World Health Organization cites LASA errors as a leading safety concern, contributing to at least one death per day and injuring 1.3 million people each year in the U.S. alone. With thousands of medications in use and many sharing similar names, even a small misread can lead to serious patient harm which makes clear, effective labeling a critical safeguard.

Key Takeaways

  • LASA medications are a leading cause of preventable errors - Look-alike, sound-alike drugs contribute significantly to medication errors, particularly in high-pressure clinical environments.
  • Small visual differences can have serious consequences - With thousands of medications in use, subtle name similarities increase the risk of misidentification and patient harm.
  • Tall Man lettering improves drug name recognition - Capitalizing distinct portions of drug names helps clinicians quickly differentiate between commonly confused medications.
  • Labels reduce cognitive load and support faster decisions - Clear, readable labels enable healthcare providers to verify medications quickly, especially during emergencies or shift changes.
  • Standardization and customization both play a role - Aligning with ISMP recommendations while tailoring labels to facility-specific risks is an effective safety strategy.
  • Consistent implementation strengthens patient safety - Training, auditing, and integrating labels across workflows ensures long-term impact and reduces variability in medication handling.

What is Tall Man Lettering?

One proven strategy to reduce LASA errors is Tall Man lettering. It’s a typographic strategy that enhances drug name visibility by capitalizing the parts of the name that differ from another, similar-looking or similar-sounding drug. For instance, hydrOXYzine and hydrALAzine may appear similar at a glance, but when Tall Man labels are applied, the distinguishing portions stand out, reducing the likelihood of confusion.

The Institute for Safe Medication Practices (ISMP), which pioneered the use of Tall Man lettering in the U.S., has published a list of recommended drug name pairs with Tall Man enhancements. Examples include:

  • DOBUTamine vs. DOPamine
  • cloNIDine vs. cloZAPine
  • vinCRIStine vs. vinBLAStine

In practice, Tall Man lettering appears on a range of critical communication tools including medication labels, electronic health record systems (EHRs), pharmacy dispensing software, IV bags, and packaging. When used consistently, it significantly enhances visibility and reduces confusion, especially in environments with high-alert medications.

Why It Matters: Reducing LASA Medication Errors

LASA errors are often the result of rushed workflows, miscommunication, and visual misidentification. According to a review published in the Journal of Patient Safety¹, LASA errors account for approximately one in every four medication errors. The consequences can be severe, particularly when the medications involved are high-alert drugs that require precise dosing and administration.

Tall Man lettering helps mitigate these risks. Studies show that capitalizing distinct sections of LASA drug names improves visual perception and helps healthcare workers correctly identify medications, even under pressure. For example, in a study by the Institute of Safe Medication Practices (ISMP), 95% of respondents said Tall Man lettering reduced selection errors, and 87% recalled specific instances where it prevented them from prescribing or dispensing the wrong medication!

In fast-paced environments such as hospital pharmacies, emergency departments, and ICUs, Tall Man lettering provides a critical layer of safety. It helps staff to quickly and accurately distinguish between medications that could otherwise be mistaken for one another.

Improving Workflow and Reducing Cognitive Load for Nurses

Nurses, especially those working long shifts or across multiple units, manage constant interruptions and competing priorities. Tools that reduce cognitive load and support quick decision-making are essential to maintaining safety.

Tall Man lettering labels act as clear, visual prompts. When used on syringe labels, IV lines, or storage bins, they enable nurses to quickly verify medication names, especially in high-stress moments or when multitasking. By minimizing reliance on memory or the need to cross-check with other sources, these labels help reduce the likelihood of error.

This is especially beneficial during handoffs, shift changes or emergencies.

Industry Standards and Support for Tall Man Lettering

Tall Man lettering is more than a best practice, it is widely supported by leading patient safety organizations, including:

Each recommends the use of Tall Man lettering as part of comprehensive medication safety strategies.

How Tall Man Lettering Labels Are Used in Clinical Settings

These labels are applied across multiple points in the medication use process:

  • Syringe labels - clearly identify LASA medications during preparation and administration.
  • IV bags and tubing labels -clarify contents during patient handoffs or multi-drug infusion setups.
  • Dispensing containers - help pharmacists and nurses distinguish look-alike drugs at the point of care.
  • Smart pump displays - reinforce accurate drug identification throughout administration.

In situations where multiple medications with similar names are prescribed concurrently, such as critical care or anesthesia and surgery, Tall Man labels are especially critical. They offer a physical, visual layer of safety that complements electronic verification systems.

Implementation Tips for Healthcare Facilities

To leverage the benefits of Tall Man lettering, healthcare facilities should take a structured approach. Here are some best practices for implementation:

  • Standardize Label Formats – Apply consistent Tall Man formatting across printed labels and electronic systems.
  • Use Authoritative Lists – Align labels with current ISMP recommendations and LASA alerts.
  • Integrate Across Systems – Ensure compatibility with printers, procurement processes, and EHR platforms.
  • Train Staff – Educate clinical teams on interpretation and proper use.
  • Audit Regularly – Review usage and compliance to ensure effectiveness.

Implementing Tall Man lettering is a small adjustment that can make a big impact. When integrated into a healthcare organization's labeling workflow, it improves accuracy, supports clinical workflows, and elevates patient safety.

United Ad Label Tall Man Labeling

United Ad Label provides healthcare organizations with labeling solutions designed to reduce LASA risk at the point of care.

  • ISMP-Aligned Designs – Tall Man lettering formats built to support recognized safety standards
  • Clinically Tested Materials – Durable labels that remain legible in demanding healthcare environments
  • Custom Solutions – Tailored labels for your facility’s highest-risk medications and workflows

Whether you’re standardizing across departments or addressing specific LASA risks, UAL helps translate safety guidelines into practical, everyday safeguards. Contact us to learn more or request samples to evaluate in your facility.

Frequently Asked Questions

What are look-alike, sound-alike (LASA) medications?

LASA medications are drugs with names that look or sound similar to one another, increasing the risk of confusion during prescribing, dispensing, or administration. Without proper safeguards in place, these similarities can lead to medication errors.

What is Tall Man lettering and how does it help?

Tall Man lettering is a formatting technique that uses uppercase letters to highlight differences in similar drug names (e.g., DOBUTamine vs. DOPamine). This makes it easier for healthcare providers to distinguish between medications and reduces the likelihood of selection errors.

Where should Tall Man lettering be used in a hospital?

Tall Man lettering should be applied wherever medications are stored, prepared, or administered. This includes syringe labels, IV bags and tubing, pharmacy dispensing systems, medication bins, and electronic health record (EHR) interfaces.

How do hospitals identify which LASA medications to prioritize?

Hospitals often use resources from the Institute for Safe Medication Practices (ISMP) along with internal error reports to develop a customized LASA list. This ensures focus on the medications most relevant to their specific workflows and risks.

Can labeling really reduce medication errors?

Yes. Studies show that clear, standardized labeling, combined with strategies like Tall Man lettering, can significantly reduce selection and administration errors.

What are best practices for implementing LASA labeling?

Best practices include standardizing label formats, aligning with ISMP recommendations, training staff, integrating labeling into workflows, and regularly auditing usage to ensure compliance and effectiveness.

How can healthcare facilities get started with improved labeling?

Facilities can begin by evaluating their current LASA risks, reviewing ISMP guidance, and implementing standardized labeling strategies. Partnering with a provider that offers both stock and custom labeling solutions can help ensure alignment with safety goals and internal protocols.

Written by: Tina Gagner
Tina serves as a Product Manager and Website Administrator for United Ad Label. She brings over 30 years of extensive experience in the healthcare and sciences industries to her work. Outside of her professional roles, she enjoys reading and gardening.

Footnotes
¹Ciociano N, Bagnasco L. Look alike/sound alike drugs: a literature review on causes and solutions. Int J Clin Pharm. 2014;36:233–242.